Trial Information

Summary: Type 2 Diabetes Research Study (people taking Actos® or Avandia®)

Attention: Type 2 Diabetics taking Actos® or Avandia® to Control their Blood Sugar Levels…

We’re conducting a research study of an investigational medication for Type II Diabetes. To qualify for this study, you must: be 18 to 77 years of age, be currently taking Actos® or Avandia® to control your blood sugar levels, have inadequate glycemic control. Qualified participants will receive all study-related care and study medication at no charge and may be compensated up to $1,150 for their time and travel.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 5:45:44 AM